AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD. - Giesige CR; Wallace LM; Heller KN; Eidahl JO; Saad NY; Fowler AM; Pyne NK; Al-Kharsan M; Rashnonejad A; Chermahini GA; Domire JS; Mukweyi D; et al. (JCI insight, 2018)